Table 2. Patient Characteristics (mRNA Assay): Higher-Risk Cohort.
- Marcus M. Schittenhelm (490220)
- Barbara Illing (490221)
- Figen Ahmut (490222)
- Katharina Henriette Rasp (490223)
- Gunnar Blumenstock (490224)
- Konstanze Döhner (490225)
- Charles D. Lopez (490226)
- Kerstin M. Kampa-Schittenhelm (490227)
Publication date
November 2013
DOIAbstract
<p>The prognostic higher-risk cohort includes AML with leukocytosis >100,000/microliter, secondary and complex karyotype AML (from MDS), therapy-related AML, biphenotypic and undifferentiated leukemia, Philadelphia-chromosome-, FLT3- or MLL-mutated myeloid or lymphoid leukemia.</p
Add to ORKG